Elipovimab Antibody
Elipovimab is a broadly neutralizing antibody targeting HIV-1. It functions by binding to and facilitating the clearance of HIV-infected cells. This makes it a valuable research tool for in vitro neutralization assays and in vivo studies exploring HIV-1 immunotherapy and eradication strategies.
Product Specifications
Target
HIV Protease
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology, Protein Biochemistry
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62094R-Cy5-01 20 µL
BCL2L12 Recombinant Antibody, Cy5 Conjugated
Sign In for Pricing
View Details bsm-62094R-Cy5-02 100 µL
BCL2L12 Recombinant Antibody, Cy5 Conjugated
Sign In for Pricing
View Details